Daffodil International University
Health Tips => Health Tips => Dengue Fever => Topic started by: Badshah Mamun on October 01, 2023, 10:34:29 AM
-
Safety and durable immunogenicity of the TV005 tetravalent dengue vaccine, across serotypes and age groups, in dengue-endemic Bangladesh: a randomised, controlled trial
Article:
https://www.sciencedirect.com/science/article/abs/pii/S1473309923005200?via%3Dihub#preview-section-snippets